Pentagon Mandates Testosterone Checks for Veteran-Ready Troops

WASHINGTON — The U.S. Defense Department has rolled out a new health screening requirement that obligates every active‑duty and reserve soldier aged 30 or older to be evaluated for low testosterone levels. Announced on July 16, the policy is part of an effort to counteract “operator syndrome,” a condition linked to hormone decline, chronic fatigue, decreased muscle endurance, sleep issues, memory lapses, and heightened stress.

Pentagon spokesman Sean Parnel indicated that the directive follows Defense Secretary Pete Hegseth’s mandate to improve force performance and ensure maximum mission readiness. The mandatory test will be administered during routine Periodic Health Assessments, while younger service members may elect to undergo testing if they wish.

The initiative dovetails with the Warfighter Performance Optimization‑Total Force Fitness (WPO‑TFF) strategy, which emphasizes a holistic approach to soldier health, incorporating physiological data, wearable sensors, and cognitive performance metrics. By establishing a baseline hormonal profile, the Pentagon aims to deliver targeted testosterone therapy to those in need, preserving a combat‑effective force.

A memorandum signed by Secretary Hegseth requires the Under Secretary for Personnel and Readiness to amend departmental policy by August 15, integrating the new screening into existing health‑assessment protocols. All service branches and the Defense Health Agency must align their internal policies, update procedures, and train medical personnel accordingly.

To support the rollout, the Defense Department will publish clinical guidance, guarantee testing availability across military treatment facilities, and convene an advisory council of external experts to monitor outcomes and recommend further enhancements to force health and performance.